5.9
CiteScore
5.9
Impact Factor
Volume 49 Issue 4
Apr.  2022
Turn off MathJax
Article Contents

The mechanisms of nucleotide actions in insulin resistance

doi: 10.1016/j.jgg.2022.01.006
Funds:

This study was supported by the starting funds from the Metabolic Disease Research Center, Zhengzhou University Affiliated Zhengzhou Central Hospital and the Center for Advanced Medicine, College of Medicine, Zhengzhou University, Zhengzhou to Jianping Ye.

  • Received Date: 2021-11-03
  • Accepted Date: 2022-01-24
  • Rev Recd Date: 2022-01-23
  • Publish Date: 2022-04-30
  • Insulin resistance contributes to metabolic disorders in obesity and type 2 diabetes. In mechanisms of insulin resistance, the roles of glucose, fatty acids, and amino acids have been extensively documented in literature. However, the activities of nucleotides remain to be reviewed comprehensively in the regulation of insulin sensitivity. Nucleotides are well known for their activities in biosynthesis of DNA and RNA as well as their signaling activities in the form of cAMP and cGAMP. Their activities in insulin resistance are dependent on the derivatives and corresponding receptors. ATP and NADH, derivatives of adenosine, inhibit insulin signaling inside cells by downregulation of activities of AMPK and SIRT1, respectively. ATP, ADP and AMP, the well-known energy carriers, regulate cellular responses to insulin outside cells through the purinergic receptors in cell surface. Current evidence suggests that ATP, NADH, cGAMP, and uridine are potential biomarkers of insulin resistance. However, GTP and cGMP are likely the markers of insulin sensitization. Here, studies crossing the biomedical fields are reviewed to characterize nucleotide activities in the regulation of insulin sensitivity. The knowledge brings new insights into the mechanisms of insulin resistance.
  • loading
  • Adinolfi, E., Giuliani, A.L., De Marchi, E., Pegoraro, A., Orioli, E., Di Virgilio, F., 2018. The P2X7 receptor: A main player in inflammation. Biochem Pharmacol. 151, 234-244
    Andres-Hernando, A., Cicerchi, C., Kuwabara, M., Orlicky, D.J., Sanchez-Lozada, L.G., Nakagawa, T., Johnson, R.J., Lanaspa, M.A., 2021. Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation. Nat Metab. 3, 1189-1201
    Auchampach, J.A., Ge, Z.D., Wan, T.C., Moore, J.,Gross, G.J., 2003. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol. 285, H607-613
    Bai, J., Cervantes, C., He, S., He, J., Plasko, G.R., Wen, J., Li, Z., Yin, D., Zhang, C., Liu, M., et al., 2020. Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity in mice. Commun Biol. 3, 257
    Bai, J., Cervantes, C., Liu, J., He, S., Zhou, H., Zhang, B., Cai, H., Yin, D., Hu, D., Li, Z., et al., 2017. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci U S A. 114, 12196-12201
    Bai, J.,Liu, F., 2019. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. Diabetes. 68, 1099-1108
    Bhansali, S., Bhansali, A., Dutta, P., Walia, R., Dhawan, V., 2020. Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study. J Cell Mol Med. 24, 2832-2846
    Burnstock, G., 2014. Purinergic signalling in endocrine organs. Purinergic Signal. 10, 189-231
    Burnstock, G., 2020. Introduction to Purinergic Signalling in the Brain. Adv Exp Med Biol. 1202, 1-12
    Burnstock, G.,Boeynaems, J.M., 2014. Purinergic signalling and immune cells. Purinergic Signal. 10, 529-564
    Cao, X., Ye, X., Zhang, S., Wang, L., Xu, Y., Peng, S., Zhou, Y., Peng, Y., Li, J., Zhang, X., et al., 2021. ADP Induces Blood Glucose Through Direct and Indirect Mechanisms in Promotion of Hepatic Gluconeogenesis by Elevation of NADH. Front Endocrinol (Lausanne). 12, 663530
    Cekic, C.,Linden, J., 2016. Purinergic regulation of the immune system. Nat Rev Immunol. 16, 177-192
    Cekic, C., Sag, D., Li, Y., Theodorescu, D., Strieter, R.M., Linden, J., 2012. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol. 188, 198-205
    Chai, S.P.,Fong, J.C., 2015. Synergistic induction of insulin resistance by endothelin-1 and cAMP in 3T3-L1 adipocytes. Biochim Biophys Acta. 1852, 2048-2055
    Chen, Y., Peng, Q., Yang, Y., Zheng, S., Wang, Y., Lu, W., 2019. The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study. BMC Public Health. 19, 1293
    Choudhary, S.A., Bora, N., Banerjee, D., Arora, L., Das, A.S., Yadav, R., Klotz, K.N., Pal, D., Jha, A.N.,Dasgupta, S., 2019. A novel small molecule A2A adenosine receptor agonist, indirubin-3'-monoxime, alleviates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes. Biochem J. 476, 2371-2391
    Cree-Green, M., Newcomer, B.R., Brown, M.S., Baumgartner, A.D., Bergman, B., Drew, B., Regensteiner, J.G., Pyle, L., Reusch, J.E.,Nadeau, K.J., 2015. Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance. Diabetes. 64, 383-392
    Csoka, B., Toro, G., Vindeirinho, J., Varga, Z.V., Koscso, B., Nemeth, Z.H., Kokai, E., Antonioli, L., Suleiman, M., Marchetti, P., et al., 2017. A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity. FASEB J. 31, 4985-4997
    de Lera Ruiz, M., Lim, Y.H., Zheng, J., 2014. Adenosine A2A receptor as a drug discovery target. J Med Chem. 57, 3623-3650
    Deng, Y., Wang, Z.V., Gordillo, R., An, Y., Zhang, C., Liang, Q., Yoshino, J., Cautivo, K.M., De Brabander, J., Elmquist, J.K., et al., 2017. An adipo-biliary-uridine axis that regulates energy homeostasis. Science. 355
    DeOliveira, C.C., Paiva Caria, C.R., Ferreira Gotardo, E.M., Ribeiro, M.L., Gambero, A., 2017. Role of A1 and A2A adenosine receptor agonists in adipose tissue inflammation induced by obesity in mice. Eur J Pharmacol. 799, 154-159
    Dufurrena, Q., Back, N., Mains, R.E., Hodgson, L., Tanowitz, H., Mandela, P., Eipper, E., Kuliawat, R., 2018. Kalirin/Trio Rho GDP/GTP exchange factors regulate proinsulin and insulin secretion. J Mol Endocrinol
    Dunwiddie, T.V.,Masino, S.A., 2001. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 24, 31-55
    Ely, S.W.,Berne, R.M., 1992. Protective effects of adenosine in myocardial ischemia. Circulation. 85, 893-904
    Faas, M.M., Saez, T.,de Vos, P., 2017. Extracellular ATP and adenosine: The Yin and Yang in immune responses? Mol Aspects Med. 55, 9-19
    Faivre, E., Coelho, J.E., Zornbach, K., Malik, E., Baqi, Y., Schneider, M., Cellai, L., Carvalho, K., Sebda, S., Figeac, M., et al., 2018. Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease. Front Mol Neurosci. 11, 235
    Ferriere, A., Santa, P., Garreau, A., Bandopadhyay, P., Blanco, P., Ganguly, D., Sisirak, V., 2020. Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome. Front Immunol. 11, 624256
    Field, J.J., Majerus, E., Gordeuk, V.R., Gowhari, M., Hoppe, C., Heeney, M.M., Achebe, M., George, A., Chu, H., Sheehan, B., et al., 2017. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 1, 1645-1649
    Figler, R.A., Wang, G., Srinivasan, S., Jung, D.Y., Zhang, Z., Pankow, J.S., Ravid, K., Fredholm, B., Hedrick, C.C., Rich, S.S., et al., 2011. Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes. 60, 669-679
    Fozard, J.R., Ellis, K.M., Villela Dantas, M.F., Tigani, B., Mazzoni, L., 2002. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol. 438, 183-188
    Frick, J.S., MacManus, C.F., Scully, M., Glover, L.E., Eltzschig, H.K., Colgan, S.P., 2009. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J Immunol. 182, 4957-4964
    Fuentes, E., Fuentes, M., Caballero, J., Palomo, I., Hinz, S., El-Tayeb, A., Muller, C.E., 2018. Adenosine A2A receptor agonists with potent antiplatelet activity. Platelets. 29, 292-300
    Fullerton, M.D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.P., O'Neill, H.M., Ford, R.J., Palanivel, R., O'Brien, M., et al., 2013. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 19, 1649-1654
    Ge, Z.D., Peart, J.N., Kreckler, L.M., Wan, T.C., Jacobson, M.A., Gross, G.J., Auchampach, J.A., 2006. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther. 319, 1200-1210
    Givertz, M.M., Massie, B.M., Fields, T.K., Pearson, L.L., Dittrich, H.C., Cki, Investigators, C.K.I., 2007. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 50, 1551-1560
    Glover, D.K., Riou, L.M., Ruiz, M., Sullivan, G.W., Linden, J., Rieger, J.M., Macdonald, T.L., Watson, D.D.,Beller, G.A., 2005. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium. Am J Physiol Heart Circ Physiol. 288, H1851-1858
    Greenberg, B., Thomas, I., Banish, D., Goldman, S., Havranek, E., Massie, B.M., Zhu, Y., Ticho, B., Abraham, W.T., 2007. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 50, 600-606
    Guo, X., Shu, C., Li, H., Pei, Y., Woo, S.L., Zheng, J., Liu, M., Xu, H., Botchlett, R., Guo, T., et al., 2017. Cyclic GMP-AMP Ameliorates Diet-induced Metabolic Dysregulation and Regulates Proinflammatory Responses Distinctly from STING Activation. Sci Rep. 7, 6355
    Hales, C.M., Fryar, C.D., Carroll, M.D., Freedman, D.S., Aoki, Y., Ogden, C.L., 2018. Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016. JAMA. 319, 2419-2429
    He, F., Huang, Y., Song, Z., Zhou, H.J., Zhang, H., Perry, R.J., Shulman, G.I., Min, W., 2021. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance. J Exp Med. 218
    Hernandez, E.A., Kahl, S., Seelig, A., Begovatz, P., Irmler, M., Kupriyanova, Y., Nowotny, B., Nowotny, P., Herder, C., Barosa, C., et al., 2017. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest. 127, 695-708
    Herzig, S., Shaw, R.J., 2018. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 19, 121-135
    Hesselink, M.K., Schrauwen-Hinderling, V., Schrauwen, P., 2016. Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus. Nat Rev Endocrinol. 12, 633-645
    Hudoyo, A.W., Hirase, T., Tandelillin, A., Honda, M., Shirai, M., Cheng, J., Morisaki, H., Morisaki, T., 2017. Role of AMPD2 in impaired glucose tolerance induced by high fructose diet. Mol Genet Metab Rep. 13, 23-29
    Hurrle, S.,Hsu, W.H., 2017. The etiology of oxidative stress in insulin resistance. Biomed J. 40, 257-262
    Jacobson, K.A., Tosh, D.K., Jain, S.,Gao, Z.G., 2019. Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development. Front Cell Neurosci. 13, 124
    Jain, S., Pydi, S.P., Jung, Y.H., Scortichini, M., Kesner, E.L., Karcz, T.P., Cook, D.N., Gavrilova, O., Wess, J., Jacobson, K.A., 2021. Adipocyte P2Y14 receptors play a key role in regulating whole-body glucose and lipid homeostasis. JCI Insight. 6
    Jesinkey, S.R., Madiraju, A.K., Alves, T.C., Yarborough, O.H., Cardone, R.L., Zhao, X., Parsaei, Y., Nasiri, A.R., Butrico, G., Liu, X., et al., 2019. Mitochondrial GTP Links Nutrient Sensing to beta Cell Health, Mitochondrial Morphology, and Insulin Secretion Independent of OxPhos. Cell Rep. 28, 759-772 e710
    Jheng, H.F., Tsai, P.J., Guo, S.M., Kuo, L.H., Chang, C.S., Su, I.J., Chang, C.R., Tsai, Y.S., 2012. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol. 32, 309-319
    Jorquera, G., Meneses-Valdes, R., Rosales-Soto, G., Valladares-Ide, D., Campos, C., Silva-Monasterio, M., Llanos, P., Cruz, G., Jaimovich, E., Casas, M., 2021. High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice. Diabetologia. 64, 1389-1401
    Kalk, P., Eggert, B., Relle, K., Godes, M., Heiden, S., Sharkovska, Y., Fischer, Y., Ziegler, D., Bielenberg, G.W., Hocher, B., 2007. The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol. 151, 1025-1032
    Laker, R.C., Drake, J.C., Wilson, R.J., Lira, V.A., Lewellen, B.M., Ryall, K.A., Fisher, C.C., Zhang, M., Saucerman, J.J., Goodyear, L.J., et al., 2017. Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy. Nat Commun. 8, 548
    Le, J., Zhang, X., Jia, W., Zhang, Y., Luo, J., Sun, Y., Ye, J., 2019. Regulation of microbiota-GLP1 axis by sennoside A in diet-induced obese mice. Acta Pharm Sin B. 9, 758-768
    Lee, J.H., Zhang, Y., Zhao, Z., Ye, X., Zhang, X., Wang, H., Ye, J., 2017. Intracellular ATP in balance of pro- and anti-inflammatory cytokines in adipose tissue with and without tissue expansion. Int J Obes. 41, 645-651
    Li, D., Zhang, Y., Liu, Y., Sun, R., Xia, M., 2015. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr. 145, 742-748
    Li, X., Kang, H., Liu, X., Liu, Z., Shu, K., Chen, X., Zhu, S., 2012. Effect of adenosine A2A receptor antagonist ZM241385 on amygdala-kindled seizures and progression of amygdala kindling. J Huazhong Univ Sci Technolog Med Sci. 32, 257-264
    Li, Y.N.,Su, Y., 2020. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING. Biochem Biophys Res Commun. 526, 381-388
    Liu, K., Qiu, D., Liang, X., Huang, Y., Wang, Y., Jia, X., Li, K., Zhao, J., Du, C., Qiu, X., et al., 2021. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. Autophagy. 1-17
    Lopez-Cruz, L., Salamone, J.D., Correa, M., 2018. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Front Pharmacol. 9, 526
    Luo, G., Huang, B., Qiu, X., Xiao, L., Wang, N., Gao, Q., Yang, W., Hao, L., 2017. Resveratrol attenuates excessive ethanol exposure induced insulin resistance in rats via improving NAD+ /NADH ratio. Mol Nutr Food Res. 61
    Luo, X., Li, H., Ma, L., Zhou, J., Guo, X., Woo, S.L., Pei, Y., Knight, L.R., Deveau, M., Chen, Y., et al., 2018. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Gastroenterology. 155, 1971-1984 e1974
    Mason, S.A., Della Gatta, P.A., Snow, R.J., Russell, A.P., Wadley, G.D., 2016. Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: Findings of a randomized controlled study. Free Radic Biol Med. 93, 227-238
    Medina, C.B., Mehrotra, P., Arandjelovic, S., Perry, J.S.A., Guo, Y., Morioka, S., Barron, B., Walk, S.F., Ghesquiere, B., Krupnick, A.S., et al., 2020. Metabolites released from apoptotic cells act as tissue messengers. Nature. 580, 130-135
    Mihara, T., Mihara, K., Yarimizu, J., Mitani, Y., Matsuda, R., Yamamoto, H., Aoki, S., Akahane, A., Iwashita, A., Matsuoka, N., 2007. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition. J Pharmacol Exp Ther. 323, 708-719
    Miotto, P.M., LeBlanc, P.J., Holloway, G.P., 2018. High-Fat Diet Causes Mitochondrial Dysfunction as a Result of Impaired ADP Sensitivity. Diabetes. 67, 2199-2205
    Mottillo, E.P., Desjardins, E.M., Crane, J.D., Smith, B.K., Green, A.E., Ducommun, S., Henriksen, T.I., Rebalka, I.A., Razi, A., Sakamoto, K., et al., 2016. Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function. Cell Metab. 24, 118-129
    Nemeth, Z.H., Bleich, D., Csoka, B., Pacher, P., Mabley, J.G., Himer, L., Vizi, E.S., Deitch, E.A., Szabo, C., Cronstein, B.N., et al., 2007. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J. 21, 2379-2388
    Pavlou, S., Lindsay, J., Ingram, R., Xu, H., Chen, M., 2018. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol. 19, 24
    Polosa, R., Blackburn, M.R., 2009. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci. 30, 528-535
    Qian, S., Ma, L., Peng, S., Xu, Y., Wu, K., Shen, S., Zhang, X., Sun, Y., Ye, J., 2020a. ATP reduces mitochondrial MECR protein in liver of diet-induced obese mice in mechanism of insulin resistance. Biosci Rep. 40
    Qian, S.N., Peng, S.Q., Zhang, X.Y., Ye, J.P., 2020b. [Novel role of intracellular ATP in obesity pathology]. Sheng Li Xue Bao. 72, 532-538
    Qiao, J., Chen, C., Shangguan, D., Mu, X., Wang, S., Jiang, L., Qi, L., 2018. Simultaneous Monitoring of Mitochondrial Temperature and ATP Fluctuation Using Fluorescent Probes in Living Cells. Anal Chem. 90, 12553-12558
    Rena, G., Hardie, D.G., Pearson, E.R., 2017. The mechanisms of action of metformin. Diabetologia. 60, 1577-1585
    Revelo, X.S., Ghazarian, M., Chng, M.H., Luck, H., Kim, J.H., Zeng, K., Shi, S.Y., Tsai, S., Lei, H., Kenkel, J., et al., 2016. Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance. Cell Rep. 16, 717-730
    Sandhu, B., Perez-Matos, M.C., Tran, S., Singhal, G., Syed, I., Feldbrugge, L., Mitsuhashi, S., Pelletier, J., Huang, J., Yalcin, Y., et al., 2021. Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism. Metabolism. 118, 154731
    Sneyd, J.R., Langton, J.A., Allan, L.G., Peacock, J.E., Rowbotham, D.J., 2007. Multicentre evaluation of the adenosine agonist GR79236X in patients with dental pain after third molar extraction. Br J Anaesth. 98, 672-676
    Sprenger, H.G., MacVicar, T., Bahat, A., Fiedler, K.U., Hermans, S., Ehrentraut, D., Ried, K., Milenkovic, D., Bonekamp, N., Larsson, N.G., et al., 2021. Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity. Nat Metab. 3, 636-650
    Steculorum, S.M., Timper, K., Engstrom Ruud, L., Evers, N., Paeger, L., Bremser, S., Kloppenburg, P.,Bruning, J.C., 2017. Inhibition of P2Y6 Signaling in AgRP Neurons Reduces Food Intake and Improves Systemic Insulin Sensitivity in Obesity. Cell Rep. 18, 1587-1597
    Stuhlmann, T., Planells-Cases, R., Jentsch, T.J., 2018. LRRC8/VRAC anion channels enhance beta-cell glucose sensing and insulin secretion. Nat Commun. 9, 1974
    Sun, Y., Jin, C., Zhang, X., Jia, W., Le, J., Ye, J., 2018. Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice. Nutr Diabetes. 8, 53
    Urasaki, Y., Pizzorno, G., Le, T.T., 2014. Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis. PLoS One. 9, e99728
    Urasaki, Y., Pizzorno, G., Le, T.T., 2016. Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice. PLoS One. 11, e0146994
    Valladares, D., Quezada, C., Montecinos, P., Concha, II, Yanez, A.J., Sobrevia, L., San Martin, R., 2008. Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli. Biochem Biophys Res Commun. 366, 180-185
    Wang, L., Yuan, L., Zeng, X., Peng, J., Ni, Y., Er, J.C., Xu, W., Agrawalla, B.K., Su, D., Kim, B., et al., 2016. A Multisite-Binding Switchable Fluorescent Probe for Monitoring Mitochondrial ATP Level Fluctuation in Live Cells. Angew Chem Int Ed Engl. 55, 1773-1776
    Wang, X., Zhang, X., Wu, D., Huang, Z., Hou, T., Jian, C., Yu, P., Lu, F., Zhang, R., Sun, T., et al., 2017. Mitochondrial flashes regulate ATP homeostasis in the heart. Elife. 6
    Wei-LaPierre, L.,Dirksen, R.T., 2019. Isolating a reverse-mode ATP synthase-dependent mechanism of mitoflash activation. J Gen Physiol. 151, 708-713
    Wu, H., Wang, Y., Li, W., Chen, H., Du, L., Liu, D., Wang, X., Xu, T., Liu, L.,C hen, Q., 2019. Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome. Autophagy. 15, 1882-1898
    Wu, Z., He, K., Chen, Y., Li, H., Pan, S., Li, B., Liu, T., Xi, F., Deng, F., Wang, H., et al., 2021. A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo. Neuron
    Xie, L., Zhang, Y., Gunasekar, S.K., Mishra, A., Cao, L.,Sah, R., 2017. Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity. Channels (Austin). 11, 673-677
    Ye, J., 2013. Mechanisms of insulin resistance in obesity. Front Med. 7, 14-24
    Ye, J., 2021. Mechanism of insulin resistance in obesity: a role of ATP. Front Med. 15, 372-382
    Zhang, J., Teran, G., Popa, M., Madapura, H., Ladds, M., Lianoudaki, D., Grunler, J., Arsenian-Henriksson, M., McCormack, E., Rottenberg, M.E., et al., 2021. DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance. iScience. 24, 102494
    Zhang, X., Qin, J., Zou, J., Lv, Z., Tan, B., Shi, J., Zhao, Y., Ren, H., Liu, M., Qian, M., et al., 2018a. Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling. Cell Mol Immunol. 15, 58-73
    Zhang, Y., Ecelbarger, C.M., Lesniewski, L.A., Muller, C.E., Kishore, B.K., 2020. P2Y2 Receptor Promotes High-Fat Diet-Induced Obesity. Front Endocrinol (Lausanne). 11, 341
    Zhang, Y., Sowers, J.R., Ren, J., 2018b. Targeting autophagy in obesity: from pathophysiology to management. Nat Rev Endocrinol. 14, 356-376
    Zhang, Y., Xie, L., Gunasekar, S.K., Tong, D., Mishra, A., Gibson, W.J., Wang, C., Fidler, T., Marthaler, B., Klingelhutz, A., et al., 2017a. SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis. Nat Cell Biol. 19, 504-517
    Zhang, Y., Zhao, Z., Ke, B., Wan, L., Wang, H., Ye, J., 2016. Induction of Posttranslational Modifications of Mitochondrial Proteins by ATP Contributes to Negative Regulation of Mitochondrial Function. PLoS One. 11, e0150454
    Zhang, Y.J., Li, M.P., Tang, J., Chen, X.P., 2017b. Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives. Int J Environ Res Public Health. 14
    Zhong, H., Shlykov, S.G., Molina, J.G., Sanborn, B.M., Jacobson, M.A., Tilley, S.L., Blackburn, M.R., 2003. Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol. 171, 338-345
    Zhu, Y., Zhao, S., Deng, Y., Gordillo, R., Ghaben, A.L., Shao, M., Zhang, F., Xu, P., Li, Y., Cao, H., et al., 2017. Hepatic GALE Regulates Whole-Body Glucose Homeostasis by Modulating Tff3 Expression. Diabetes. 66, 2789-2799
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (310) PDF downloads (20) Cited by ()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return